Overview

Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.
Details
(Image credit: Mackenzie Calle for NPR)
Source
Originally published at www.npr.org.
Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.

Origin Genomics aims to prove the potential benefits of its technology for editing disease-causing genes in human embryos outweigh the risks.
(Image credit: Mackenzie Calle for NPR)
Originally published at www.npr.org.